Black and white huh. So Vanguard doesn't own any? So the Biotech ETF's don't own any? As for disclaimers, you ever listen to an ad for any drug? They all have disclaimers. Very few companies however suggest their shareholders may soon be holding worthless paper.
By than Xtandi will be well entrenched and I suspect bought out. Unlike the untruthful claims of a generic being available now its at least two years away. I will be long gone by than. Hopefully there will be new more effective products on the way also, Thats the way the game goes.
The people pumping DNDN do not have a very good track record. Place your bets where you wish and we will see who comes out ahead. Fantasy postings of $40 a share buyouts when your trading under $2 with threats of bankruptcy at your door? Good luck.
"101% owned by hedge fund insiders", wrong. Institutional ownership is high but they are not all hedge funds. As long as you DNDN followers continue to ignore reality and try and bend any news in your favor you will have a hard time making money. Spending more time interpreting your 10Q than worrying about MDVN holders would be a good start.
No, whats strange is that you are worried about last years sales. The market looks forward and earnings forecast for MDVN are being revised upward on a weekly basis. Some are suggesting 2 billion in sales in a year.
MDVN's fortunes are riding on Xtandi. Astellas has a broad stable of products which include half of Xtandi. As a result Astellas will be less volatile with most likely less upside potential. Widows and Orphans would do well with Astellas. I believe Bearofbleecker bought some Astellas a while back and can weigh in here.
Most people don't like helping those who come across as rude. I know the answer but would have tailored it to your specific reason for wanting to know. Given your reply you can learn on your own.
Peso If you haven't noticed the longs do not care to here opposing views. The free lessons they refuse will be replaced with a very hard and expensive lesson.
Perhaps a better question is why do you ask? What possible difference does it make? I have traded for over 35 years and have never once worried about nor heard anyone else ask why a stock is OTC.
If thats the basis for your investment theory you will be very disappointed.
Enough with the conspiracy theories people. As for shorts working the boards to depress the price, you have got to be kidding. Do you really believe people are trading based on the messages on this board? Even if they were it would represent a minuscule amount of the action and would not budge the price.
Have you seen "experts in the field" revise sales estimates for DNDN or its competition based on these new treatment guidelines? How did the stock prices react?
Usually new clowns arrive after big news. Instead we get the same old stick. Maybe tomorrow?
Thank you for your concern and wealth of knowledge. Once you grow up and start investing real money you will learn that stock prices typically reflect such information (although your generic Zytiga claim is false as is the just as effective claim, actually your whole post is wrong).
I actually like the technology but suspect it will soon be available at a much lower price. I just get a kick out of the posts over there from the loyal following who refuse to listen to reason, or bluntly worded 10Q's.
The reopening in after hours seems to have taken the luster off this. It will be interesting to see if the market continues to yawn at this news during regular trading.
You have a funny definition of bashing. If pointing out possible reasons for a stock trading at 3% of its previous high, as opposed to the conspiracy theories is bashing, than yes I am a basher.